Laboratory experiments as well as clinical trials have shown that PIK3CA-mutated CRC cells are especially dependent on glutamine for survival compared to PIK3CA wildtype cells [67, 342–344]. This evidence concerns the gene PIK3CA and colorectal carcinoma.